Shots:

• The company launched the new NfL blood test that allows doctors to identify and verify signs of neurodegenerative disease along with diagnosing and treat patients more quickly & effectively
• The test measures key biomarkers associated with neuronal damage; assists in the diagnosis of diseases incl. MS, AD Parkinson’s, or brain injury. It is anticipated that having a wide range of diagnostic tools available to doctors will have a positive impact on the ability to diagnose & treat numerous conditions more successfully
• The test's launch and availability showed Labcorp's dedication to neurology and to enhance the health and lives of people suffering from neurodegenerative and related disorders

Ref: Bussinesswire | Image: Labcorp